Spencer Park

Spencer Park is a Director at AstraZeneca, leveraging extensive experience in cell therapy research and development. They previously served as a Senior Scientist and Principal Scientist at Lyell Immunopharma and as a Postdoctoral Research Fellow at Pfizer. Spencer's academic background includes a PhD in Biomedical Engineering from Weill Cornell Graduate School and a BS in Biological/Biosystems Engineering from Cornell University. Earlier roles included research positions at New York Medical College and Weill Cornell Medicine, where they contributed to studies on cancer therapies and patient ventilation methods. Spencer also completed a venture capital program at GoingVC in 2024.